Immuneering (IMRX) Other Non-Current Assets (2020 - 2026)

Immuneering's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $278129.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 65.7% year-over-year to $278129.0; the TTM figure through Mar 2026 stood at $278129.0 (down 65.7% YoY), while the FY2025 annual figure was $283562.0, down 78.12% from the prior year.
• Other Non-Current Assets was $278129.0 for Q1 2026 at Immuneering, down from $283562.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $1.3 million in Q4 2024 to a low of $89579.0 in Q1 2022.
• Historically, Other Non-Current Assets has averaged $753538.4 across 5 years, with a median of $743703.0 in 2022.
• Biggest YoY gain for Other Non-Current Assets was 5044.02% in 2022; the steepest drop was 90.67% in 2022.
• A 5-year view of Other Non-Current Assets shows it stood at $743703.0 in 2022, then jumped by 39.09% to $1.0 million in 2023, then climbed by 25.26% to $1.3 million in 2024, then tumbled by 78.12% to $283562.0 in 2025, then retreated by 1.92% to $278129.0 in 2026.
• The last three Other Non-Current Assets figures came in at $278129.0 (Q1 2026), $283562.0 (Q4 2025), and $631297.0 (Q3 2025), per Business Quant data.